Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Study reveals peripheral blood biomarkers able to predict COVID-19 clinical outcomes in ICU admission

by Medical Finance
in Coronavirus
Study: Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes. Image Credit: kentoh/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to overwhelm the delivery of healthcare throughout the world. The emergence of SARS-CoV-2 variants of concern and vaccine hesitancy are two factors that are mainly responsible for this.

Study: Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes. Image Credit: kentoh/ShutterstockStudy: Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes. Image Credit: kentoh/Shutterstock


Individual patient responses to SARS-CoV-2 infections can range from asymptomatic or mild flu-like symptoms to severe symptoms that include acute respiratory distress syndrome (ARDS) and death. Severe cases of SARS-CoV-2 infection are associated with obesity, age, comorbidities, or secondary infections. Systemic corticosteroids and tocilizumab are administered for severe patients since both symptoms and conventional clinical measurements do not have adequate prognostic powers.

Immunologically severe patients have been found to exhibit neutrophilia, lymphopenia, emergency myelopoiesis, accumulation of lung monocytes, and changes in serum cytokine and chemokine responses. A few of the previous markers have been of interest for the development of prognostic tools. However, they have lacked the necessary statistical power to accurately predict the likelihood of severe disease.

Studies on cellular changes have indicated that severe disease is associated with decreased frequency of monocytes. Although they provide important information on the immune response against SARS-CoV-2 infections, they are yet to be translated into prognostic tools.

A new study published in the pre-print server medRxiv* involved the development of an immunological biomarker screen that upon ICU admission can predict the length of ICU stay or death.

About the study

The study involved the collection of blood samples from SARS-CoV-2 positive patients within 48 hours of ICU admission between November 2020 and February 2021. For control, blood samples were collected from healthy volunteers who had no previous COVID-19 history or any COVID-19 symptom.

Patient demographic, as well as clinical information, were also collected. The patients were then classified into two groups, “Short Stay” and “Long-Stay/Died”. The “Short Stay” patients were those who spend less than 6 days in the ICU while “Long Stay/Died” patients were those who stay for more than 6 days or until death in the ICU.

Thereafter, peripheral blood mononuclear cells (PBMC) were isolated from the collected blood samples. The PBMCs were used for antibody staining as well as mass cytometry (CyTOF) data collection followed by quantification of serum cytokines.

Findings

The results reported no significant differences in age, clinical outcome, body mass index (BMI), serum C-reactive protein (CRP) levels, blood clotting parameters, PBMC counts between the Short Stay and Long Stay/Died groups. However, the mean ICU admission levels of serum IL-10 and TNFα were found to be higher in the Long-Stay/Died group as compared to the Short Stay group. A more significant difference in the levels of IL-10 and TNFα was reported on the examination of post-admission samples between the two groups.

No major difference in the levels of B, T, NK, and myelomonocytic cells were reported between the Short Stay and Long-Stay/Died group. The CD11c classical monocyte level was found to be higher in the Long-Stay/Died group as compared to the Short-Stay group. Although T cell subset alterations were reported in the patients as compared to healthy controls, no significant difference between the two groups was observed.

The results also indicated that length of ICU stay could be more accurately correlated with serum IL-10 levels as compared to serum TNFα levels. Therefore, a diagnostic tool was developed with serum IL-10 levels and levels of CD11c classical monocyte. This tool was found to have 91 percent accuracy in the determination of the clinical outcome of COVID-19 patients newly admitted to ICU.

The current study, therefore, indicates that a combination of two biomarkers at the time of ICU admission could help to determine the length of ICU stay or death in patients with severe SARS-CoV-2 infections. These biomarkers can also be important as temporal monitoring tools to determine disease trajectory as well as responses against therapeutic approaches.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Plasma SARS-CoV-2 RNA levels as a biomarker of lower respiratory tract SARS-CoV-2 infection in critically ill patients with COVID-19. Image Credit: CROCOTHERY/Shutterstock

Plasma SARS-CoV-2 viral RNA as a valuable biomarker for SARS-CoV-2 infection in the lungs

by Medical Finance
May 20, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers evaluated plasma and lower respiratory tract (LRT) severe acute...

Study: Putative host-derived insertions in the genome of circulating SARS-CoV-2 variants. Image Credit: Andrii Vodolazhskyi/Shutterstock

Investigating the presence of human rRNA in the SARS-CoV-2 genome

by Medical Finance
May 20, 2022
0

In a recent study posted to the bioRxiv* pre-print server, a team of researchers investigated the existence of severe acute...

Study: Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis. Image Credit: Haris Mm/Shutterstock

Effect of emerging SARS-CoV-2 variants and vaccination status on COVID-19 transmission rates

by Medical Finance
May 20, 2022
0

In a recent study published in the medRxiv* preprint server, a team of researchers determined the impact of the emerging severe...

KHN’s ‘What the Health?’: Dealing with drug prices

KHN’s ‘What the Health?’: Dealing with drug prices

by Medical Finance
May 20, 2022
0

Medicare officials have preliminarily decided to restrict reimbursement for Aduhelm, the controversial Alzheimer's drug, to only patients participating in approved...

Researchers analyze the role of self-deception in everyday life

Justices block broad worker vaccine requirement, allow health worker mandate to proceed

by Medical Finance
May 20, 2022
0

The Supreme Court on Thursday blocked a key Biden administration covid-19 initiative — putting a stop, for now, to a...

New evidence supports the link between growth-induced respiratory stress and fish reproduction

What patients can learn with confidence from one negative rapid test (hint: very little)

by Medical Finance
May 20, 2022
0

Julie Ann Justo, an infectious disease clinical pharmacist for a South Carolina hospital system, hoped Christmas week would finally be...

Next Post
Study: Nano-vectors for CRISPR/Cas9-mediated genome editing. Image Credit: Meletios Verras/Shutterstock

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Study: The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness. Image Credit: CROCOTHERY/Shutterstock

Study explores role of APOBEC-mediated RNA editing in SARS-CoV-2 fitness

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Understanding Evolution of COVID-19 Driven Mortality Rate. Image Credit: Cryptographer / Shutterstock.com
    Determining evolution of COVID-19 mortality rates using machine-learning
  • Twin cameras sit either side of the print head and comprise the Iris™ Optical QC System which captures images of printed slides within 300 msof sample deposition.
    Optimal printing of DMSO for compound library microarray screening
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply